학술논문
Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial
Document Type
Article
Author
Source
In Journal of Thoracic Oncology February 2021 16(2):299-309
Subject
Language
ISSN
1556-0864